SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-21-002790
Filing Date
2021-03-17
Accepted
2021-03-17 16:53:18
Documents
1
Period of Report
2021-03-16

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 7466
  Complete submission text file 0001062993-21-002790.txt   9007
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Issuer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O ENDOCYTE, INC., 3000 KENT AVENUE SUITE A1-100 WEST LAFAYETTE IN 47906
Business Address
McAvoy David R. (Reporting) CIK: 0001758842 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21088 | Film No.: 21751203